Piper Sandler analyst Paul Newsome initiated coverage of Bowhead Specialty (BOW) with an Overweight rating and $44 price target The firm says Bowhead is a high growth specialty insurer with a history of profitability and an experienced management team. owhead is an affiliate of AmFam for statutory purposes which reduces the company’s statutory capital requirements, the analyst tells investors in a research note. Piper says the company is operating in high growth profitable markets.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BOW:
- Strong Growth and Strategic Positioning Drive Buy Rating for Bowhead Specialty Holdings Inc.
- Bowhead Specialty price target raised to $40 from $38 at Citizens JMP
- Bowhead Specialty price target lowered to $33 from $34 at Morgan Stanley
- Bowhead Specialty price target lowered to $43 from $44 at Keefe Bruyette
- Bowhead Specialty price target raised to $35 from $30 at JPMorgan